VARDENAFIL
Vardenafil Adverse Events Reported to the FDA Over Time
How are Vardenafil adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Vardenafil, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Vardenafil is flagged as the suspect drug causing the adverse event.
Most Common Vardenafil Adverse Events Reported to the FDA
What are the most common Vardenafil adverse events reported to the FDA?
| Erectile Dysfunction | 1817 (13.4%) |
| Drug Ineffective | 971 (7.16%) |
| Headache | 745 (5.49%) |
| Flushing | 346 (2.55%) |
| Adverse Event | 289 (2.13%) |
| Dizziness | 257 (1.9%) |
| Nasal Congestion | 253 (1.87%) |
| Erection Increased | 242 (1.78%) |
| Vision Blurred | 195 (1.44%) |
| Nausea | 145 (1.07%) |
| Drug Effect Decreased | 125 (.92%) |
 Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Vardenafil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vardenafil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Adverse Event Categories for Vardenafil
What are the most common Vardenafil adverse events reported to the FDA?
| Sexual Function And Fertility | 2370 (17.48%) |
| Therapeutic And Nontherapeutic Effe... | 1534 (11.31%) |
| Vision | 836 (6.17%) |
| Headaches | 791 (5.83%) |
| Neurological | 625 (4.61%) |
| Gastrointestinal Signs | 471 (3.47%) |
| Vascular | 401 (2.96%) |
| Upper Respiratory Tract Disorders | 319 (2.35%) |
| Cardiac And Vascular Investigations | 271 (2%) |
| Respiratory | 252 (1.86%) |
| Epidermal And Dermal Conditions | 223 (1.64%) |
| Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Vardenafil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vardenafil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Common Uses of Vardenafil According to Those Reporting Adverse Events
Why are people taking Vardenafil, according to those reporting adverse events to the FDA?
| Erectile Dysfunction | 3731 |
| Drug Use For Unknown Indication | 1041 |
| Product Used For Unknown Indication | 86 |
| Sexual Dysfunction | 48 |
| Ill-defined Disorder | 35 |
| Unevaluable Event | 17 |
| Show More |
Drug Labels
| Label | Labeler | Effective |
|---|---|---|
| Levitra | PD-Rx Pharmaceuticals, Inc. | 08-JUL-10 |
| Levitra | Schering Plough Corporation | 08-JUL-10 |
| Levitra | Physicians Total Care, Inc. | 08-JUL-10 |
| Staxyn | Schering Plough Corporation | 12-APR-11 |
| Levitra | PD-Rx Pharmaceuticals, Inc. | 22-APR-11 |
| Levitra | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 26-OCT-11 |
| Levitra | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 26-OCT-11 |
| Levitra | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 27-OCT-11 |
| Levitra | KAISER FOUNDATION HOSPITALS | 08-NOV-11 |
| Staxyn | Physicians Total Care, Inc. | 23-APR-12 |
| Staxyn | GlaxoSmithKline LLC | 11-JUL-12 |
| Levitra | GlaxoSmithKline LLC | 12-JUL-12 |
| Levitra | Bryant Ranch Prepack | 17-JAN-13 |
Vardenafil Case Reports
What Vardenafil safety concerns are being reported by doctors and researchers in the medical literature?
About Results
This report contains aggregated drug side effects and adverse events for Vardenafil. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Comments
Share your experience with Vardenafil.